Daniel E. Everitt

Urinary excretion of 6β‐hydroxycortisol as an in vivo marker for CYP3A induction: Applications and recommendations

D. Jorkasky, S. J. Kovacs, D. Martin, 1998, Clinical pharmacology and therapeutics.

The neglected medical history and therapeutic choices for abdominal pain. A nationwide study of 799 physicians and nurses.

J. Avorn, D. Everitt, M. Baker, 1991, Archives of internal medicine.

Medicaid data as a resource for epidemiologic studies: strengths and limitations.

J. Avorn, R. Bright, D. Everitt, 1989, Journal of clinical epidemiology.

Beta-blockers and depression. Evidence against an association.

R. Bright, D. Everitt, Daniel E. Everitt, 1992, JAMA.

Systemic effects of medications used to treat glaucoma.

J. Avorn, D. Everitt, Daniel E. Everitt, 1990, Annals of internal medicine.

Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.

J. Avorn, J. Gurwitz, H. Mogun, 1995, The American journal of medicine.

Psychoactive medication use in intermediate-care facility residents.

J. Avorn, S. Soumerai, M. Beers, 1988, JAMA.

Treatment for glaucoma: adherence by the elderly.

J. Avorn, R. Glynn, J. Gurwitz, 1993, American journal of public health.